Founded in 2002, Huayin Jinqiancheng Pharmaceutical Co., Ltd. specializes in the R&D and production of APIs, chemical intermediate and salicylic acid products. The registered capital is 11.18 million Yuan RMB, and the actual capital is nearly 90 million Yuan RMB at present. In 2004, the company passed the State Food and Drug Administration (SFDA) GMP certificate, it owns self-managerial import and export right. In January 26, 2013, the company passed FDA audit. The company has registered NDC No. in D&B. At present, the company is actively preparing to submit DMF, COS, REACH and relevant documents of products to the U.S., Europe and other relevant countries. The annual turnover is 50 million US dollar and 75% of sales is coming from oversea market.